Literature DB >> 27903804

Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.

René G P van Gennip1, Sandra G P van de Water2, Christiaan A Potgieter3,4, Piet A van Rijn2,3.   

Abstract

The Reoviridae family consists of nonenveloped multilayered viruses with a double-stranded RNA genome consisting of 9 to 12 genome segments. The Orbivirus genus of the Reoviridae family contains African horse sickness virus (AHSV), bluetongue virus, and epizootic hemorrhagic disease virus, which cause notifiable diseases and are spread by biting Culicoides species. Here, we used reverse genetics for AHSV to study the role of outer capsid protein VP2, encoded by genome segment 2 (Seg-2). Expansion of a previously found deletion in Seg-2 indicates that structural protein VP2 of AHSV is not essential for virus replication in vitro In addition, in-frame replacement of RNA sequences in Seg-2 by that of green fluorescence protein (GFP) resulted in AHSV expressing GFP, which further confirmed that VP2 is not essential for virus replication. In contrast to virus replication without VP2 expression in mammalian cells, virus replication in insect cells was strongly reduced, and virus release from insect cells was completely abolished. Further, the other outer capsid protein, VP5, was not copurified with virions for virus mutants without VP2 expression. AHSV without VP5 expression, however, could not be recovered, indicating that outer capsid protein VP5 is essential for virus replication in vitro Our results demonstrate for the first time that a structural viral protein is not essential for orbivirus replication in vitro, which opens new possibilities for research on other members of the Reoviridae family. IMPORTANCE: Members of the Reoviridae family cause major health problems worldwide, ranging from lethal diarrhea caused by rotavirus in humans to economic losses in livestock production caused by different orbiviruses. The Orbivirus genus contains many virus species, of which bluetongue virus, epizootic hemorrhagic disease virus, and African horse sickness virus (AHSV) cause notifiable diseases according to the World Organization of Animal Health. Recently, it has been shown that nonstructural proteins NS3/NS3a and NS4 are not essential for virus replication in vitro, whereas it is generally assumed that structural proteins VP1 to -7 of these nonenveloped, architecturally complex virus particles are essential. Here we demonstrate for the first time that structural protein VP2 of AHSV is not essential for virus replication in vitro Our findings are very important for virologists working in the field of nonenveloped viruses, in particular reoviruses.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  AHSV; orbivirus; reovirus; reverse genetics; structural protein VP2; virus replication

Mesh:

Substances:

Year:  2017        PMID: 27903804      PMCID: PMC5286882          DOI: 10.1128/JVI.01328-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach.

Authors:  P A van Rijn; S G P van de Water; H G P van Gennip
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

2.  Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.

Authors:  C D DeMaula; K R Bonneau; N J MacLachlan
Journal:  Virus Res       Date:  2000-03       Impact factor: 3.303

3.  In vitro reconstitution of Bluetongue virus infectious cores.

Authors:  Sofia Lourenco; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

Review 4.  Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication.

Authors:  Polly Roy
Journal:  Cell Biochem Biophys       Date:  2008-02-26       Impact factor: 2.194

5.  Structure of bluetongue virus particles by cryoelectron microscopy.

Authors:  E A Hewat; T F Booth; P Roy
Journal:  J Struct Biol       Date:  1992 Jul-Aug       Impact factor: 2.867

6.  Sequence analysis of bluetongue virus serotype 8 from the Netherlands 2006 and comparison to other European strains.

Authors:  Sushila Maan; Narender S Maan; Natalie Ross-smith; Carrie A Batten; Andrew E Shaw; Simon J Anthony; Alan R Samuel; Karin E Darpel; Eva Veronesi; Chris A L Oura; Karam P Singh; Kyriaki Nomikou; Abraham C Potgieter; Houssam Attoui; Eugene van Rooij; Piet van Rijn; Kris De Clercq; Frank Vandenbussche; Stéphan Zientara; Emmanuel Bréard; Corinne Sailleau; Martin Beer; Bernd Hoffman; Philip S Mellor; Peter P C Mertens
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

7.  Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles.

Authors:  F Guirakhoo; J A Catalan; T P Monath
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Evidence for a new field Culicoides vector of African horse sickness in South Africa.

Authors:  R Meiswinkel; J T Paweska
Journal:  Prev Vet Med       Date:  2003-08-28       Impact factor: 2.670

9.  Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.

Authors:  Femke Feenstra; Barbara S Drolet; Jan Boonstra; Piet A van Rijn
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

10.  Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.

Authors:  Lizahn Zwart; Christiaan A Potgieter; Sarah J Clift; Vida van Staden
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more
  3 in total

1.  Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus.

Authors:  René G P van Gennip; Barbara S Drolet; Paula Rozo Lopez; Ashley J C Roost; Jan Boonstra; Piet A van Rijn
Journal:  Parasit Vectors       Date:  2019-10-11       Impact factor: 3.876

Review 2.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07

3.  A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.

Authors:  Mine Aksular; Eva Calvo-Pinilla; Alejandro Marín-López; Javier Ortego; Adam C Chambers; Linda A King; Javier Castillo-Olivares
Journal:  Vaccine       Date:  2018-10-08       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.